Total Payments
$6,321
2024 Payments
$3,000
Companies
4
Transactions
23
Medicare Patients
905
Medicare Billing
$442,125
Payment Breakdown by Category
Research$3,000 (47.5%)
Consulting$1,724 (27.3%)
Other$1,000.00 (15.8%)
Food & Beverage$597.23 (9.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3,000 | 1 | 47.5% |
| Consulting Fee | $1,724 | 1 | 27.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 15.8% |
| Food and Beverage | $597.23 | 20 | 9.4% |
Payments by Type
General
$3,321
22 transactions
Research
$3,000
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Brainsway USA INC | $5,832 | 4 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $316.78 | 5 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $105.45 | 6 | $0 (2021) |
| Neuronetics, Inc. | $66.56 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,000 | 1 | Brainsway USA INC ($3,000) |
| 2023 | $1,374 | 4 | Brainsway USA INC ($1,108) |
| 2022 | $1,724 | 1 | Brainsway USA INC ($1,724) |
| 2021 | $26.60 | 2 | Otsuka America Pharmaceutical, Inc. ($15.40) |
| 2020 | $20.36 | 1 | Otsuka America Pharmaceutical, Inc. ($20.36) |
| 2019 | $81.41 | 8 | Neuronetics, Inc. ($33.77) |
| 2018 | $72.89 | 5 | Janssen Pharmaceuticals, Inc ($34.68) |
| 2017 | $22.36 | 1 | Otsuka America Pharmaceutical, Inc. ($22.36) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Brainsway USA INC | Brainsway Deep TMS System (Device) | — | Cash or cash equivalent | $3,000.00 | Research |
| Study: Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects • Category: Neurology | ||||||
| 12/12/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Neuroscience | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $115.17 | General |
| Category: Neuroscience | ||||||
| 06/02/2023 | Brainsway USA INC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 06/02/2023 | Brainsway USA INC | — | Food and Beverage | Cash or cash equivalent | $108.44 | General |
| 04/01/2022 | Brainsway USA INC | Brainsway Deep TMS (Device) | Consulting Fee | Cash or cash equivalent | $1,723.64 | General |
| Category: Transcranial Magnetic Stimulation | ||||||
| 12/21/2021 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | Cash or cash equivalent | $11.20 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 05/11/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PSYCHIATRY | ||||||
| 01/31/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 11/18/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 04/12/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 03/20/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neuroscience | ||||||
| 03/14/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 03/08/2019 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 12/21/2018 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 05/22/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: PSYCHIATRY | ||||||
| 05/04/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Neuroscience | ||||||
| 03/28/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Neuroscience | ||||||
| 02/26/2018 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 02/08/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: PSYCHIATRY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects | Brainsway USA INC | $3,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 45 | 802 | $426,475 | $105,939 |
| 2022 | 2 | 32 | 455 | $253,625 | $60,556 |
| 2021 | 6 | 284 | 1,237 | $326,209 | $109,971 |
| 2020 | 10 | 544 | 2,227 | $432,133 | $165,658 |
Total Patients
905
Total Services
4,721
Medicare Billing
$442,125
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 25 | 781 | $410,650 | $103,338 | 25.2% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2023 | 20 | 21 | $15,825 | $2,601 | 16.4% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 17 | 440 | $242,000 | $58,527 | 24.2% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2022 | 15 | 15 | $11,625 | $2,029 | 17.5% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 14 | 412 | $226,600 | $59,404 | 26.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 73 | 349 | $37,343 | $19,564 | 52.4% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Facility | 2021 | 72 | 328 | $32,472 | $16,391 | 50.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 38 | 45 | $13,545 | $6,293 | 46.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 61 | 71 | $11,289 | $5,727 | 50.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 32 | $4,960 | $2,592 | 52.3% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 13 | 364 | $200,200 | $50,808 | 25.4% |
| 90833 | Psychotherapy, 30 minutes | Facility | 2020 | 101 | 786 | $77,814 | $40,763 | 52.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 98 | 665 | $71,155 | $37,870 | 53.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 79 | 86 | $25,886 | $12,993 | 50.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 85 | 123 | $19,065 | $9,854 | 51.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 87 | 103 | $16,377 | $8,568 | 52.3% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 13 | 13 | $10,075 | $1,774 | 17.6% |
| 90869 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 11 | 11 | $8,525 | $1,500 | 17.6% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Facility | 2020 | 43 | 45 | $2,385 | $1,184 | 49.6% |
| 90785 | Interactive complexity | Facility | 2020 | 14 | 31 | $651.00 | $343.45 | 52.8% |
About Dr. Mark Blair, MD
Dr. Mark Blair, MD is a Psychiatry healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194755504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Blair, MD has received a total of $6,321 in payments from pharmaceutical and medical device companies, with $3,000 received in 2024. These payments were reported across 23 transactions from 4 companies. The most common payment nature is "" ($3,000).
As a Medicare-enrolled provider, Blair has provided services to 905 Medicare beneficiaries, totaling 4,721 services with total Medicare billing of $442,125. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Columbus, OH
- Active Since 07/03/2006
- Last Updated 12/09/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1194755504
Products in Payments
- Brainsway Deep TMS System (Device) $3,000
- Brainsway Deep TMS (Device) $1,724
- SPRAVATO (Drug) $282.10
- ABILIFY MAINTENA (Drug) $105.45
- NEUROSTAR TMS THERAPY (Device) $66.56
- INVEGA SUSTENNA (Drug) $34.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbus
Fred Romeo, Md, MD
Psychiatry — Payments: $2.3M
Psychiatry $2.3M
Michael Saribalas
Psychiatry — Payments: $1.3M
Psychiatry $1.3M
Kevin Ware, Md, MD
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Peter Zafirides, Md, MD
Psychiatry — Payments: $127,832
Psychiatry $127,832
Dr. Benjamin Roy, M.d, M.D
Psychiatry — Payments: $102,125
Psychiatry $102,125
Barbara Gracious, M.d, M.D
Psychiatry — Payments: $58,986
Psychiatry $58,986